QuickView for RET;jsessionid=28E14966EE595DCD567764566C5CEDB0;jsessionid=90F21E5DC6AE637884667A7BEE2D8307;jsessionid=85854E9034F273664C241658ABAFA306;jsessionid=416DEA89C9CAC39AD324CE1C2A310D69;jsessionid=BE9ABFEEF196883135098D9485E1A062 (gene)

1. Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease an…
2. Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge binders.
3. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both…
4. Progress and challenges in RET-targeted cancer therapy.
5. Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.

There were no clinical trials for RET;jsessionid=28E14966EE595DCD567764566C5CEDB0;jsessionid=90F21E5DC6AE637884667A7BEE2D8307;jsessionid=85854E9034F273664C241658ABAFA306;jsessionid=416DEA89C9CAC39AD324CE1C2A310D69;jsessionid=BE9ABFEEF196883135098D9485E1A062